There was a problem loading this video.
    Please refresh the page or watch it on Vimeo.

    ResAppDx empowers clinicians to remotely assess respiratory disease with confidence

    Coviu has partnered with ResApp Health to facilitate remote respiratory testing using the ResAppDx app to help clinicians assess a patient’s respiratory symptoms and accurately diagnose their illness.

     

    RA_COV_teal_cough

     

    RA_COV_teal_Validated

     

    RA_COV_teal_instantresults

     

    Remote respiratory smartphone testing

    Clinically validated, TGA approved medical device

    Instant Results

    Patients take the ‘cough test’ using the ResAppDx app to aid you in your diagnosis of common respiratory diseases.

    Results proven in large Australian clinical studies. Read our scientific publications.

    Analysis report available during the session to help you confidently assess patient’s symptoms.

     

    Remote Respiratory Testing for Patients

    Step1-1

     

    Step2-1

     

    Step3-1

     

    Symptom Check

    Perform Respiratory Cough Test

    Join the Call

    Patients are asked if they are experiencing these symptoms: fever, coughing, difficulty breathing, shortness of breath, runny nose, sore throat.

    Patients take the test using the ResAppDx app to capture five coughs.
    Their coughs are instantly analysed.

    Patients will then speak with their doctor to discuss the test results.

     

    Frequently Asked Questions 

    What can ResAppDx aid in the diagnosis of?
    How do I enable ResAppDx Respiratory Test add-on?
    How much does the ResAppDx Respiratory Test add-on cost?
    What happens after the ResAppDx Respiratory Test add-on is enabled?
    Who can take the test?
    How much does the respiratory test cost for patients?
    When does the patient take the respiratory cough test?
    Does the patient have to have coughing symptoms to take the test?
    What is in the ResAppDx Analysis Report?
    Does the patient receive the ResAppDx Analysis Report?
    Where can I review the clinical performance for ResAppDx?
    What smartphones are compatible with ResAppDx?

    Disclaimer: Only indicated for use on patients aged 29 days and older. The result of the test should not be used as a sole diagnosis. The result should be used as part of an overall clinical assessment of the patient. Please refer to the Instructions for Use for information on interpreting the results and the clinical performance of ResAppDx. ResAppDx is listed on the Australian Register of Therapeutic Goods (ARTG). Always follow and read the Instructions for Use.

    Powered by

    ResApp-Logo-2048w